Table 2 Patients’ characteristics before and after ATO treatment
From: Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
Patient No. | No. of RBC transfusions per week (mean units) | platelet count (×109/L) | Haemoglobin (g/dL) | ANC (× 109/L) | ||||
|---|---|---|---|---|---|---|---|---|
Before ATO therapy | After maximum response to ATO | Before ATO therapy | After maximum response to ATO | Before ATO therapy | After maximum responseto ATO | Before ATO therapy | After maximum response to ATO | |
1 | 1.8 | Transfusion independence | 9 | 115 | 5.1 | 11.4 | 0.2 | 2.0 |
2 | 1.9 | Transfusion independence | 11 | 73 | 5.3 | 8.6 | 0.1 | 0.8 |
3 | 2.3 | Transfusion independence | 14 | 138 | 4.9 | 11.2 | 0.3 | 1.9 |
4 | 2.6 | Transfusion independence | 9 | 107 | 6.1 | 12.3 | 0.2 | 2.2 |
5 | 1.9 | Transfusion independence | 5 | 67 | 5.7 | 8.8 | 0.2 | 0.9 |